[Current therapeutic strategy of hepatocellular carcinoma with extensive portal thrombus].
Ken Shirabe, Mitsuo Shimada, Shinji Tanaka, Takashi Maeda, Yoshihiko Maehara
Abstract
Ken Shirabe, Mitsuo Shimada, Shinji Tanaka, Takashi Maeda, Yoshihiko Maehara
Abstract
Prognosis of the patients with hepatocellular carcinoma with tumor thrombi in the portal vein is known to be extremely poor. The current results of various therapies, such as surgery, chemotherapy, immuno-therapy, radiation and combination therapy were reviewed, herein. Our recent therapeutic strategy for hepatocellular carcinoma with tumor thrombi in portal vein is also shown.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Prognosis of the patients with hepatocellular carcinoma with tumor thrombi in the portal vein is known to be extremely poor. The current results of various therapies, such as surgery, chemotherapy, immuno-therapy, radiation and combination therapy were reviewed, herein. Our recent therapeutic strategy for hepatocellular carcinoma with tumor thrombi in portal vein is also shown.
Key concepts: Hepatocellular carcinoma, Medicine, Portal vein, Radiology, Radiation therapy, Thrombus, Portal hypertension, Chemotherapy